PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Reletrans
Presentation Product Chemical substance Chapter Items dispensed
Reletrans 5micrograms/hour transdermal patches
0407020B0BKAAAH
Reletrans Buprenorphine Central Nervous System 18,368
Reletrans 10micrograms/hour transdermal patches
0407020B0BKABAI
Reletrans Buprenorphine Central Nervous System 17,592
Reletrans 20micrograms/hour transdermal patches
0407020B0BKADAJ
Reletrans Buprenorphine Central Nervous System 9,232
Reletrans 15micrograms/hour transdermal patches
0407020B0BKACAK
Reletrans Buprenorphine Central Nervous System 8,744
Reletrans 25microgram/hour transdermal patches
0407020B0BKAEAL
Reletrans Buprenorphine Central Nervous System 207
Reletrans 30micrograms/hour transdermal patches
0407020B0BKAFAM
Reletrans Buprenorphine Central Nervous System 141
Reletrans 40micrograms/hour transdermal patches
0407020B0BKAGAN
Reletrans Buprenorphine Central Nervous System 56

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.